Evidence map›Paper›PMID 40881745›Full record

ArticleWorld journal of transplantation2025

Comparison of a direct

James Zhang, Todd Nagamine, Kimberly Vu, Mohammed Ali, Nath Limpruttidham, Maan Gozun, Jesus Pino Moreno, Dipanjan Banerjee

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of transplantation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

James ZhangDepartment of Cardiovascular Medicine, University of Washington, Seattle, WA 98195, United States.
Todd NagamineDepartment of Medicine, The John A Burns School of Medicine, University of Hawai'i, Honolulu, HI 96813, United States.
Kimberly VuDepartment of Medicine, The John A Burns School of Medicine, University of Hawai'i, Honolulu, HI 96813, United States.
Mohammed AliDepartment of Medicine, The John A Burns School of Medicine, University of Hawai'i, Honolulu, HI 96813, United States.
Nath LimpruttidhamDepartment of Medicine, The John A Burns School of Medicine, University of Hawai'i, Honolulu, HI 96813, United States.
Maan GozunDepartment of Medicine, The John A Burns School of Medicine, University of Hawai'i, Honolulu, HI 96813, United States.
Jesus Pino MorenoDepartment of Medicine, The John A Burns School of Medicine, University of Hawai'i, Honolulu, HI 96813, United States.
Dipanjan BanerjeeDepartment of Medicine, The John A Burns School of Medicine, University of Hawai'i, Honolulu, HI 96813, United States. dipanjan@hawaii.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdvanced heart failure and transplant (AHFTC) teams are crucial in the management of patients in cardiogenic shock. We sought to explore the impact of AHFTC physicians on outcomes in patients receiving extracorporeal membrane oxygenation (ECMO) support.

aimTo determine whether outcomes differ in the care of ECMO patients when AHFTC physicians serve in a primary

methodsWe conducted a retrospective cohort study of 51 patients placed on veno-venous (VV) and veno-arterial (VA) ECMO between January 2015 and February 2023 at our institution. We compared ECMO outcomes between teams managed primarily by intensivists

resultsFor combined VA and VV ECMO patients, survival to 30 days post discharge in the AHFTC cohort was significantly higher (67%

conclusionThis study suggests that patients in shock requiring VA ECMO support may have improved survival 30 days after hospital discharge when an AHFTC team serves in a direct role in the selection and management of patients. Further studies are needed to validate this impact.

Indexed as

Advanced heart failure and transplant cardiologyCritical careExtracorporeal membrane oxygenationHeart failureMortality

Identifiers

PMID40881745
PMCPMC12038605

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.